HCPLive Network

BCIS Myocardial Jeopardy Score Predicts Post-PCI Death

 
FRIDAY, Jan. 18 (HealthDay News) -- The British Cardiovascular Intervention Society myocardial jeopardy score (BCIS-JS) predicts mortality after percutaneous coronary intervention (PCI), according to research published in the Jan. 15 issue of The American Journal of Cardiology.

Kalpa De Silva, M.B.B.S., of King's College London, and colleagues conducted a retrospective study involving 660 patients who underwent PCI with previous left ventricular function assessment. Of these, 221 patients had previously undergone coronary artery bypass grafting (CABG). Blinded observers calculated the BCIS-JS before (BCIS-JSPRE) and after (BCIS-JSPOST) PCI, and the extent of revascularization was quantified using the revascularization index (RI; RI = [BCIS-JSPRE − BCIS-JSPOST]/BCIS-JSPRE).

The researchers found that both BCIS-JSPRE and BCISJSPOST scores were directly related to all-cause mortality (hazard ratios [HRs], 2.96 and 4.02, respectively). Other independent predictors of mortality included having a RI of less than 0.67 (HR, 1.99), left ventricular dysfunction (HR, 2.03), and renal impairment (HR, 3.75), in multivariate analysis.

"The present findings have demonstrated that the BCIS-JS has prognostic significance in a contemporary cohort of patients undergoing PCI. Higher BCIS-JSPRE and BCIS-JSPOST scores are associated with increased mortality and the BCIS-JS-derived RI is an independent predictor of mortality," the authors write. "Our findings confirm that the BCIS-JS is a highly reproducible, valid angiographic scoring tool and supports its use in risk stratification and guiding PCI in patients with coronary artery disease, including patients who have undergone previous CABG."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Isolated systolic high blood pressure in young adulthood is a predictor of cardiovascular disease mortality 30 years down the road, a new study suggests. The report was published in the Feb. 3 issue of Journal of the American College of Cardiology.
People with diabetes are less likely to take their diabetes medications if they've been diagnosed with cancer, researchers report. The findings were published online Jan. 28 in Diabetologia.
For liver transplantation recipients with model for end-stage liver disease scores above 11, survival benefit increases with decreasing serum sodium values, according to a study published online Dec. 11 in Liver Transplantation.
More Reading